Antidiabetic in pharma franchise in Mizoram

Antidiabetic in PCD pharma franchise in Bengaluru

Antidiabetic in top pharma company in Indore

Antidiabetic in pcd pharma supplier in Lucknow

Antidiabetic in phama franchise company in india
Antidiabetic in phama distributor in Patna

Home/Products /glimepiride-1mg-metformin-500mg-pioglitazone-tablet

Gimtype MP1 Tablet

Composition : Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹130/-

Glimtype MP1 Tablet is a bi-layered formulation that combines three potent antidiabetic agents: Glimepiride (1mg), Metformin (500mg), and Pioglitazone (15mg). This combination works synergistically to effectively control blood sugar levels in individuals with type 2 diabetes mellitus (T2DM).

Diabetes is a chronic condition that requires multifaceted treatment strategies to maintain optimal blood glucose levels and reduce the risk of complications. Gimtype MP1 helps regulate glucose metabolism by stimulating insulin secretion, improving insulin sensitivity, and reducing hepatic glucose production, making it a reliable choice for diabetes management.

How Gimtype MP1 Works:

Glimepiride (1mg): A sulfonylurea that stimulates pancreatic beta cells to increase insulin secretion, thereby lowering blood glucose levels.
Metformin (500mg): A biguanide that reduces glucose production in the liver, enhances insulin sensitivity, and improves glucose uptake in muscles.
Pioglitazone (15mg): A thiazolidinedione that enhances insulin sensitivity by acting on peripheral tissues, leading to better glucose utilization and reduced insulin resistance.

Read More

About the Product

Glimtype MP1 Tablet is a bi-layered formulation that combines three potent antidiabetic agents: Glimepiride (1mg), Metformin (500mg), and Pioglitazone (15mg). This combination works synergistically to effectively control blood sugar levels in individuals with type 2 diabetes mellitus (T2DM).

Diabetes is a chronic condition that requires multifaceted treatment strategies to maintain optimal blood glucose levels and reduce the risk of complications. Gimtype MP1 helps regulate glucose metabolism by stimulating insulin secretion, improving insulin sensitivity, and reducing hepatic glucose production, making it a reliable choice for diabetes management.

How Gimtype MP1 Works:

Glimepiride (1mg): A sulfonylurea that stimulates pancreatic beta cells to increase insulin secretion, thereby lowering blood glucose levels.
Metformin (500mg): A biguanide that reduces glucose production in the liver, enhances insulin sensitivity, and improves glucose uptake in muscles.
Pioglitazone (15mg): A thiazolidinedione that enhances insulin sensitivity by acting on peripheral tissues, leading to better glucose utilization and reduced insulin resistance.

May include hypoglycemia (low blood sugar), nausea, dizziness, weight gain, edema, gastrointestinal discomfort, or mild liver enzyme elevation. Seek medical advice if symptoms persist.

Used in the management of type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate glycemic control.

Take this medication exactly as prescribed by a healthcare professional. Regular blood sugar monitoring is essential to avoid hypoglycemia or hyperglycemia. Follow a healthy diet and exercise routine for optimal diabetes management.

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation